|
Volumn 37, Issue 3, 2005, Pages 1438-1440
|
Two doses of daclizumab with delayed introduction of low-dose tacrolimus in elderly recipients of cadaveric renal transplants from donors >55 years of age
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DACLIZUMAB;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
STEROID;
TACROLIMUS;
ACUTE GRAFT REJECTION;
ADULT;
AGED;
CADAVER KIDNEY;
CAUSE OF DEATH;
CEREBROVASCULAR ACCIDENT;
CHICKENPOX;
CONFERENCE PAPER;
CREATININE BLOOD LEVEL;
CYTOMEGALOVIRUS INFECTION;
DEATH;
DIABETES MELLITUS;
DIARRHEA;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
FOLLOW UP;
GERIATRICS;
GRAM NEGATIVE INFECTION;
HEMODIALYSIS;
HERPES ZOSTER;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INCIDENCE;
KIDNEY BIOPSY;
KIDNEY FUNCTION;
KIDNEY GRAFT;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
LEUKOPENIA;
LOW DRUG DOSE;
LUNG ASPERGILLOSIS;
MAJOR CLINICAL STUDY;
MALE;
MORTALITY;
MYCOSIS;
PNEUMONIA;
PREOPERATIVE TREATMENT;
PRIORITY JOURNAL;
PYELONEPHRITIS;
SEPSIS;
SEPTICEMIA;
URINARY TRACT INFECTION;
VIRUS INFECTION;
AGED;
ANTIBODIES, MONOCLONAL;
CADAVER;
CREATININE;
DRUG THERAPY, COMBINATION;
GRAFT REJECTION;
HUMANS;
IMMUNOGLOBULIN G;
KIDNEY TRANSPLANTATION;
MIDDLE AGED;
TACROLIMUS;
TISSUE DONORS;
|
EID: 19044396242
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2005.02.039 Document Type: Conference Paper |
Times cited : (12)
|
References (7)
|